Keywords: Daiichi Sankyo, Diagnogreen, Astellas, Sawacillin, Indications, Japan

Additional indications in Japan for Diagnogreen and Sawacillin

Article | 22 February 2012

Print This

Japanese drug major Daiichi Sankyo (TYO: 4568) says it has received approval in Japan for a supplemental New Drug Application ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in